Amoy Diagnostics Co (SZSE:300685) Net Change in Cash : ¥128 Mil (TTM As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Amoy Diagnostics Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Amoy Diagnostics Co's Net Change in Cash for the three months ended in Jun. 2024 was ¥31 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 was ¥128 Mil.

Amoy Diagnostics Co Net Change in Cash Historical Data

The historical data trend for Amoy Diagnostics Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amoy Diagnostics Co Net Change in Cash Chart

Amoy Diagnostics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

300.16

-136.83

-130.82

12.86

-42.51

Amoy Diagnostics Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Net Change in Cash	Get a 7-Day Free Trial															21.75	-32.21	5.74	122.67	31.40

Amoy Diagnostics Co Net Change in Cash Calculation

Amoy Diagnostics Co's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	298.716	+	-331.994	+	-18.044	+	8.809
	=	-43

Amoy Diagnostics Co's Net Change in Cash for the quarter that ended in Jun. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 58.571 + 57.194 + -85.945 + 1.579

= 31

Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥128 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amoy Diagnostics Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Amoy Diagnostics Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Amoy Diagnostics Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Amoy Diagnostics Co Ltd (SZSE:300685) » Definitions » Net Change in Cash

Comparable Companies

SZSE:300463 SZSE:300396 SZSE:300406 SZSE:300639 SHSE:603108 SZSE:301060 SZSE:300439 SHSE:688468 SZSE:301257 SHSE:603122 TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN

Traded in Other Exchanges

N/A

Address

39 Dingshan Road, Haicang District, Xiamen, CHN, 361027

Website

http://www.amoydx.com

Amoy Diagnostics Co Ltd is the pharmaceutical company based in China. The company primarily focuses on molecular diagnostics for oncology precision medicine. It provides diagnostic products and services for medicine development and clinical oncology practice. The company's products include gene mutation, nucleic acid extraction, and molecular diagnostic kits comprising EGFR, RAS, ALK, BRAF, PIK3CA, and ROS1 testing kits.

Executives

Ruan Li Directors, executives

Zheng Hui Bin Directors, executives

Chen Ying Directors, executives

Luo Jie Min Executives

Zhu Guan Shan Directors, executives

Yang Shou Qian Securities Affairs Representative

Zhou Wen Gang Executives

Zhou Xue Lin Independent director

Hu Xu Bo Director

Amoy Diagnostics Co Headlines

No Headlines

Ruan Li	Directors, executives
Zheng Hui Bin	Directors, executives
Chen Ying	Directors, executives
Luo Jie Min	Executives
Zhu Guan Shan	Directors, executives
Yang Shou Qian	Securities Affairs Representative
Zhou Wen Gang	Executives
Zhou Xue Lin	Independent director
Hu Xu Bo	Director